~2 spots leftby Apr 2026

Virtual Reality for Sphincter of Oddi Dysfunction

Recruiting in Palo Alto (17 mi)
SL
Overseen bySimon Lo, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Cedars-Sinai Medical Center
No Placebo Group
Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?

This trial is testing if virtual reality (VR) can help manage chronic pain in patients with type-3 Sphincter of Oddi dysfunction (SOD III). These patients often do not respond to usual treatments and risk opioid addiction. VR creates an engaging 3D experience that distracts the brain from pain. The study aims to see if this method can reduce pain and lower opioid use. Virtual reality (VR) has been shown to effectively manage both acute and chronic pain by providing cognitive distractions and potentially reducing opioid use.

Do I have to stop taking my current medications for the trial?

The trial does not specify if you need to stop taking your current medications. However, if you are on antidepressants for pain control, you should have been taking them for at least one month before the trial. If you are receiving treatment for depressive or anxiety disorders, your medication dose must be stable for at least 6 weeks before the trial.

What data supports the idea that Virtual Reality for Sphincter of Oddi Dysfunction is an effective treatment?

The available research does not provide specific data supporting the effectiveness of Virtual Reality for Sphincter of Oddi Dysfunction. The studies focus on other treatments for this condition and discuss the challenges in diagnosing and treating it. There is some research on Virtual Reality for urinary incontinence, showing improvements in muscle function and quality of life, but these results are similar to traditional methods. More research is needed to determine if Virtual Reality is effective for Sphincter of Oddi Dysfunction.12345

What safety data exists for Virtual Reality therapy?

The available research indicates that Virtual Reality (VR) therapy is generally safe across various applications. In a study involving older adults with cognitive and physical impairments, no negative side effects were reported, and participants tolerated the VR experience well. Another study on VR therapy for anxiety disorders showed a deterioration rate of 4.0%, which is comparable to other therapeutic approaches and lower than waiting list control groups. However, the safety and effectiveness of VR combined with an omnidirectional walking platform remain unclear, as further research is needed to assess these aspects.678910

Is Virtual Reality a promising treatment for Sphincter of Oddi Dysfunction?

The research articles provided do not mention Virtual Reality as a treatment for Sphincter of Oddi Dysfunction. They focus on other treatments like endoscopic procedures and surgery. Therefore, there is no information to suggest that Virtual Reality is a promising treatment for this condition.1451112

Research Team

SL

Simon Lo, MD

Principal Investigator

Cedars-Sinai Medical Center

Eligibility Criteria

This trial is for adults with chronic pain from Sphincter of Oddi Dysfunction (SOD) who haven't found relief through usual treatments. They should not have liver, pancreas, or bile duct issues and must be stable on any antidepressants or psychopharmacologic drugs for at least one month. Participants need to speak English and have access to a cell phone.

Inclusion Criteria

I have been taking antidepressants for pain for at least one month.
My average pain score is 3 or more on a scale of 10.
I have been on a stable dose of medication for my depression or anxiety for at least 6 weeks.
See 4 more

Exclusion Criteria

I have had pancreatitis, gallstones, or bile duct issues.
Non-English speaking subjects or subjects unable to consent to study due to cognitive difficulty will not be included in the study
Patients with a history of motion sickness and vertigo and anyone experiencing active nausea or vomiting (including pregnant women) will be excluded
See 3 more

Treatment Details

Interventions

  • Virtual Reality (Behavioural Intervention)
Trial OverviewThe study tests if Virtual Reality (VR) using Oculus Go can help manage chronic pain in outpatient settings for those with type-3 SOD. It aims to see if immersive VR experiences can reduce the intensity of their ongoing abdominal pain.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Virtual RealityExperimental Treatment1 Intervention
Every participant is provided with a VR headset

Find a Clinic Near You

Who Is Running the Clinical Trial?

Cedars-Sinai Medical Center

Lead Sponsor

Trials
523
Recruited
165,000+
David E. Cohen profile image

David E. Cohen

Cedars-Sinai Medical Center

Chief Medical Officer

MD and PhD in Physiology and Biophysics from Harvard University

Peter L. Slavin profile image

Peter L. Slavin

Cedars-Sinai Medical Center

Chief Executive Officer

MD from Harvard Medical School, MBA from Harvard Business School

Findings from Research

Endoscopic and surgical treatments for sphincter of Oddi dysfunction show similar outcomes, but both have considerable failure rates, highlighting the challenges in accurately diagnosing the condition.
The difficulties in diagnosis and the potential for sphincter of Oddi dysfunction to be part of a broader gastrointestinal motility disorder complicate the selection of appropriate patients for treatment.
Diagnosis and treatment of sphincter of Oddi dysfunction.Tzovaras, G., Rowlands, BJ.[2017]
In a study of 74 patients with postcholecystectomy pain followed for an average of 36 months, specific predictors such as intermittent pain, nausea or vomiting, and a pain-free interval of at least one year after cholecystectomy were identified as indicators of a positive response to sphincterotomy treatment.
When two or three of these predictors were present, 85% of Type 2 SOD patients and 56% of Type 3 patients experienced significant improvement, suggesting that these clinical features can help identify which Type 3 patients may benefit from surgical intervention.
Improved predictors of outcome in postcholecystectomy pain.Topazian, M., Hong-Curtis, J., Li, J., et al.[2022]
Virtual reality-based pelvic floor muscle training (PFMT) shows promise in improving muscle function and quality of life for patients with urinary incontinence, but the evidence is limited to only two randomized controlled trials involving 79 patients.
The meta-analysis indicated that traditional PFMT was more effective than VR-based PFMT in reducing urinary incontinence symptoms, highlighting the need for more research to fully understand the potential of VR interventions in this area.
Use of Virtual Reality-Based Therapy in Patients with Urinary Incontinence: A Systematic Review with Meta-Analysis.Rutkowska, A., Salvalaggio, S., Rutkowski, S., et al.[2022]

References

Diagnosis and treatment of sphincter of Oddi dysfunction. [2017]
Improved predictors of outcome in postcholecystectomy pain. [2022]
Use of Virtual Reality-Based Therapy in Patients with Urinary Incontinence: A Systematic Review with Meta-Analysis. [2022]
[Sphincter of Oddi dysfunction--prolonged medical therapy or early endoscopic sphincter ablation]. [2016]
[Management of Oddi sphincter dyskinesis. Results of drug therapy and sphincterotomy]. [2017]
Immersive virtual reality for shoulder rehabilitation: evaluation of a physical therapy program executed with oculus quest 2. [2023]
Home-based Upper Extremity Stroke Therapy Using a Multiuser Virtual Reality Environment: A Randomized Trial. [2020]
Older Adults With Cognitive and/or Physical Impairments Can Benefit From Immersive Virtual Reality Experiences: A Feasibility Study. [2020]
Deterioration rates in Virtual Reality Therapy: An individual patient data level meta-analysis. [2020]
Potential of the omnidirectional walking platform with virtual reality as a rehabilitation tool. [2023]
Long-term symptomatic relief following surgical sphincteroplasty for sphincter of Oddi dysfunction. [2021]
[Management of hypertensive dyskinesia of Oddi's sphincter. Correlation between the frequency of complications from endoscopic sphincterotomy and the diameter of the common bile duct]. [2009]